Latest Articles

Publication Date
[Pain medicine aspects of the updated S2k guideline "Diagnosis and treatment of endometriosis"].

The scheduled update of the S2k guideline "Diagnosis and treatment of endometriosis", published by the Association of the Scientific Medical Societies in Germany (AWMF; registry number 015/045), was released on …

Published: June 11, 2026, midnight
ENDO-GYM: A holistic approach with pelvic floor physiotherapy and Yoga for endometriosis pain relief.

To retrospectively evaluate the impact of ENDO-GYM Program, which combined Yoga practice and pelvic floor physiotherapy (PFP), on women with ultrasound and/or post-operative histological diagnosis of endometriosis pain resistant to …

Published: June 11, 2026, midnight
Cartherics secures Japanese patent to bolster cell therapy push - PharmaDispatch

Cartherics secures Japanese patent to bolster cell therapy push PharmaDispatch

Published: June 10, 2026, 12:17 a.m.
Gut microbiota and diet in endometriosis: a missing link in therapy?

Published: June 10, 2026, midnight
Role of hormonal therapies in endometriosis: balancing efficacy and safety.

Endometriosis is a chronic, estrogen-dependent inflammatory disorder requiring long-term management strategies that balance efficacy with systemic safety. Although hormonal therapies remain the cornerstone of treatment, the optimal degree of estrogen …

Published: June 10, 2026, midnight
Multiple recurrences of postmenopausal endometriosis associated with estrogen pellet therapy: clinical implications for hormone therapy and surgical management.

To challenge the perception that endometriosis uniformly regresses after menopause by presenting the case of repeated, pathology-confirmed symptomatic recurrences spanning two decades after menopause, and to emphasize key considerations for …

Published: June 9, 2026, midnight
The RUBY trial: For certain patients, immunotherapy-chemo combination keeps advanced endometrial cancer from progressing for years - MSN

The RUBY trial: For certain patients, immunotherapy-chemo combination keeps advanced endometrial cancer from progressing for years MSN

Published: June 8, 2026, 8:37 p.m.
Breaking the endometriosis-stroke axis: lesion-focused hydrogel reprogramming of thromboinflammatory networks.

Endometriosis is a chronic, systemic inflammatory disorder characterized by the ectopic implantation of endometrial-like tissue and accompanied by persistent pain and infertility. Beyond the pelvis, accumulating epidemiological evidence indicates that …

Published: June 8, 2026, midnight
Anti-NRP1 peptide-engineered ROS/pH dual-responsive nanoparticles for Alpelisib delivery regulate Sema3A-NRP1/PI3K-AKT signaling to balance oxidative stress and inhibit angiogenesis in endometriosis.

Endometriosis progression is driven by oxidative stress and excessive angiogenesis within an inflammatory microenvironment. To overcome these challenges, we designed ROS/pH dual-responsive Alpelisib-loaded nanoparticles (Alp@TAT-AT7-NPs) functionalized with an anti-NRP1 peptide …

Published: June 6, 2026, midnight
Women ‘blindsided’ as critical hormone therapy pulled from shelves - Herald Sun

Women ‘blindsided’ as critical hormone therapy pulled from shelves Herald Sun

Published: June 4, 2026, 8:38 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!